Cerevel Therapeutics
CERE
$40.74
Share price
0.25%
Change (1 day)
25.16%
Change (1 year)
Categories
Cerevel Therapeutics (CERE) Fails to deliver data
Key failure to deliver metrics for Cerevel Therapeutics:
- Last SEC data release: 2024-05-14
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $1.01 M
- Last year FTD volume: $53.56 M
Failures to deliver for Cerevel Therapeutics (CERE) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Cerevel Therapeutics (CERE) - since 2020
Volume in USD (price x number of shares), data since 2020Cerevel Therapeutics (CERE) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.21 M | -98.05% |
| 2023 | $62.35 M | 289.39% |
| 2022 | $16.01 M | -39.91% |
| 2021 | $26.64 M | 1389.35% |
| 2020 | $1.78 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | $0.10 B | $0.14 B | 🇺🇸 USA |
 Campbell Soup CPB | $32.39 M | $88.57 M | 🇺🇸 USA |
 Dow DOW | $12.79 M | $50.66 M | 🇺🇸 USA |
 Dupont De Nemours DD | $4.86 M | $59.21 M | 🇺🇸 USA |